The social media giant plans to cut its workforce. But this difficult move could be exactly what the market needs to see to ...
Hosted on MSN
Philip O’Doherty briefs US business delegation on remarkable journey from DuPont to E+I/Vertiv
The E+I Engineering founder was guest speaker at an AwakenHub event on the benefits of expanding into the US in Derry. One of ...
6d
Bristol-Myers Squibb: The Market Is Not Pricing The Growth Portfolio That Replaces The Patent Cliff
Bristol-Myers Squibb (BMY) looks undervalued at 8.9x forward P/E; see growth catalysts, FDA/Phase 3 timelines, and a $68 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results